Literature DB >> 1825950

The cost of hospitalization for the late complications of diabetes in the United States.

J Jacobs1, M Sena, N Fox.   

Abstract

Estimates of the cost of diabetes should take into account the development of complications. Patient records identified from the 1987 National Hospital Discharge Survey were used to evaluate the risk of hospitalization due to late complications. Hospitalization for diabetic nephropathy reached a peak of 6.74/1000 between the ages of 45 and 54 years, compared to 0.14 to 1.80/1000 in controls. Diabetic patients less than or equal to 45 years of age were 46 times more likely to be hospitalized due to neuropathy. The risk of cardiovascular complications is high, with a greater incidence of arterial than venous disorders. Diabetic patients were 22 times more likely to be admitted for skin ulcers/gangrene, 15 times more likely due to peripheral vascular disease, and 10 times due to atherosclerosis. The risk of cerebrovascular accident and heart disease was 6 to 10 times greater in diabetic patients. Seventy-five per cent of diabetic cardiovascular disorders are myocardial infarction or chronic ischaemia. Hospitalization from renal complications occurs at younger ages than in the general population. Ophthalmic complications increase with age. Diabetic complications account for 2% of the total hospital admissions in the US in 1987. The total cost of the treatment of late diabetic complications was estimated at +5091 million (cardiovascular 74%; renal diseases 10%; nephropathy 3.6%; ophthalmic disorders 1.5%; other unspecified diseases 10%).

Entities:  

Mesh:

Year:  1991        PMID: 1825950     DOI: 10.1111/j.1464-5491.1991.tb02151.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  8 in total

1.  Absence of mannose-binding lectin prevents hyperglycemic cardiovascular complications.

Authors:  Vasile I Pavlov; Laura R La Bonte; William M Baldwin; Maciej M Markiewski; John D Lambris; Gregory L Stahl
Journal:  Am J Pathol       Date:  2011-11-08       Impact factor: 4.307

Review 2.  Direct and indirect costs of cardiovascular and cerebrovascular complications of type II diabetes.

Authors:  K M MacLeod; J E Tooke
Journal:  Pharmacoeconomics       Date:  1995       Impact factor: 4.981

Review 3.  Diabetes mellitus and the St Vincent Declaration. The economic implications.

Authors:  B Leese
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

4.  Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.

Authors: 
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

5.  Mannose-binding lectin plays a critical role in myocardial ischaemia and reperfusion injury in a mouse model of diabetes.

Authors:  M N Busche; M C Walsh; M E McMullen; B J Guikema; G L Stahl
Journal:  Diabetologia       Date:  2008-05-21       Impact factor: 10.122

6.  Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase.

Authors:  Mahesh Thirunavukkarasu; Suresh Varma Penumathsa; Srikanth Koneru; Bela Juhasz; Lijun Zhan; Hajime Otani; Debasis Bagchi; Dipak K Das; Nilanjana Maulik
Journal:  Free Radic Biol Med       Date:  2007-05-10       Impact factor: 7.376

7.  Development and implementation of a computer-generated reminder system for diabetes preventive care.

Authors:  D S Nilasena; M J Lincoln; C W Turner; H R Warner; V A Foerster; J W Williamson; B M Stults
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1994

8.  Quality and Cost of Diabetes Mellitus Care in Community Health Centers in the United States.

Authors:  Patrick Richard; Peter Shin; Tishra Beeson; Laura S Burke; Susan F Wood; Sara Rosenbaum
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.